VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
A method of immunotherapy to treat cancer or a synergistic anti-cancer treatment by administering an effective amount of a natural cytokine mixture (NCM), an effective amount of cyclophosphamide (CY), or an effective amount of indomethacin (INDO), wherein the NCM, CY, or INDO are administered singly or in communications thereof. An anti-metastatic treatment method by promoting differentiation and maturation of immature dendritic cells in a lymph node; allowing presentation thereof; and preventing development of metastasis. A method of using an NCM as a diagnostic skin test for predicting treatment outcome. A method of pre-treating dendritic cells (DC) and a method of treating monocyte defects characterized by sinus histiocytosis or a negative NCM skin test. Compositions and methods for eliciting an immune response to endogenous or exogenous tumor antigens.
1 - 16 . (canceled)
17 . A synergistic anti-cancer composition comprising an effective amount of CY; an effective amount of NSAID; and an effective amount of an NCM including cytokines selected from the group consisting essentially of IL-1, IL-2, IL-6, IL-8, IL-12, IFN-γ, TNF-α, GM-CSF, G-CSF, recombinants thereof, and combinations thereof.
18 - 29 . (canceled)
30 . A composition for eliciting an immune response to endogenous or exogenous tumor antigens comprising an effective amount of an NCM including cytokines selected from the group consisting essentially of IL-1, IL-2, IL-6, IL-8, IL-12, IFN-γ, TNF-α, GM-CSF, G-CSF, recombinants thereof and combinations thereof.
31 . The composition according to claim 30 , wherein said composition further comprises an effective amount of CY.
32 . The composition according to claim 31 , wherein said composition includes an effective amount of NSAID.